Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
Website: bms.com


  • Bad financial results growth rate -11.1% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-7.5%)
  • Dividend yield for the last twelve months 4.3%
  • Free cash flow yield -14.3% (LTM)
  • Share price is 40.3% higher than minimum and 31.4% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-25.5x vs
    )

Key Financials (Download financials)

Ticker: BMY
Share price, USD:  (+0.5%)55.64
year average price 49.90  


year start price 50.00 2024-01-16

min close price 39.66 2024-07-05

max close price 59.94 2024-12-02

current price 55.71 2025-01-14
Common stocks: 2 111 517 922

Dividend Yield:  4.3%
FCF Yield LTM: -14.3%
EV / LTM EBITDA: -25.5x
EV / EBITDA annualized: 31.7x
Last revenue growth (y/y):  +8.7%
Last growth of EBITDA (y/y):  -30.8%
Historical revenue growth:  +1.7%
Historical growth of EBITDA:  -16.8%
Target EV / EBITDA (hist percentile):
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 117 485
Net Debt ($m): 46 150
EV (Enterprise Value): 163 635
EBITDA LTM ($m): -6 419
EV / LTM EBITDA: -25.5x
Price to Book: 6.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-01-14zacks.com

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

2025-01-13seekingalpha.com

Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

2025-01-10247wallst.com

Look Out, Interest Rate Cuts Could Be Over: Buy These High-Yield Passive Income Stars Now

2025-01-09fool.com

This Unpopular Dividend Stock Is a Buy

2025-01-08zacks.com

Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?

2025-01-06247wallst.com

The Magnificent 7 Blue-Chip Dividend Stocks to Buy in 2025 and Hold Forever

2025-01-03zacks.com

Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors

2024-12-31zacks.com

Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?

2024-12-31fool.com

2 High-Yield Dividend Stocks to Buy Early in 2025

2024-12-30seekingalpha.com

Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo 'Subcu' Approval
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data